Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,673Revenue $M6,464Net Margin (%)69.6Z-Score1.0
Enterprise Value $M22,498EPS $17.2Operating Margin %17.0F-Score7
P/E(ttm))3.6Cash Flow Per Share $5.7Pre-tax Margin (%)6.4Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %31.8Quick Ratio0.7Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %16.4Current Ratio0.5Lower Leverage y-yY
Price/Cash Flow6.2y-y EBITDA Growth Rate %1.7ROA % (ttm)27.2Higher Current Ratio y-yY
Dividend Yield %0.3Insider Buy (3m)0ROE % (ttm)90.3Less Shares Outstanding y-yN
Payout Ratio %1.1Shares Outstanding M269ROI % (ttm)3.9Gross Margin Increase y-yY

Gurus Latest Trades with VMED

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VMEDDaniel Loeb 2013-03-31 Buy 10.1%$36.75 - $48.97
($43.23)
$ 50.3616%New holding, 11000000 sh.11,000,000
VMEDSteve Mandel 2013-03-31 Buy 1.4%$36.75 - $48.97
($43.23)
$ 50.3616%New holding, 5659808 sh.5,659,808
VMEDGeorge Soros 2013-03-31 Add0.87%$36.75 - $48.97
($43.23)
$ 50.3616%Add 958.36%1,674,850
VMEDJean-Marie Eveillard 2013-03-31 Buy 0.08%$36.75 - $48.97
($43.23)
$ 50.3616%New holding, 508555 sh.508,555
VMEDMario Gabelli 2013-03-31 Buy 0.03%$36.75 - $48.97
($43.23)
$ 50.3616%New holding, 109730 sh.109,730
VMEDJohn Griffin 2013-03-31 Reduce-1.54%$36.75 - $48.97
($43.23)
$ 50.3616%Reduce -64.13%1,650,000
VMEDAndreas Halvorsen 2013-03-31 Sold Out -0.51%$36.75 - $48.97
($43.23)
$ 50.3616%Sold Out0
VMEDRay Dalio 2013-03-31 Sold Out -0.12%$36.75 - $48.97
($43.23)
$ 50.3616%Sold Out0
VMEDJohn Griffin 2012-12-31 Buy 2.4%$29.92 - $36.79
($33.49)
$ 50.3650%New holding, 4600000 sh.4,600,000
VMEDAndreas Halvorsen 2012-12-31 Buy 0.51%$29.92 - $36.79
($33.49)
$ 50.3650%New holding, 2014200 sh.2,014,200
VMEDGeorge Soros 2012-12-31 Buy 0.07%$29.92 - $36.79
($33.49)
$ 50.3650%New holding, 158250 sh.158,250
VMEDJoel Greenblatt 2012-12-31 Sold Out -0.02%$29.92 - $36.79
($33.49)
$ 50.3650%Sold Out0
VMEDJoel Greenblatt 2012-09-30 Buy 0.02%$24.11 - $30.44
($27.15)
$ 50.3686%New holding, 10116 sh.10,116
VMEDRay Dalio 2012-09-30 Reduce-0.06%$24.11 - $30.44
($27.15)
$ 50.3686%Reduce -30.67%393,279
VMEDDavid Einhorn 2012-06-30 Buy 1.9%$21.46 - $25.33
($23.29)
$ 50.36116%New holding, 4920000 sh.4,920,000
VMEDRay Dalio 2012-06-30 Add0.14%$21.46 - $25.33
($23.29)
$ 50.36116%Add 222.12%567,279
VMEDRay Dalio 2012-03-31 Reduce-0.03%$21.5 - $25.93
($22.86)
$ 50.36120%Reduce -32.58%176,108
VMEDRay Dalio 2011-12-31 Add0.04%$20.66 - $27.89
($23.74)
$ 50.36112%Add 62.23%261,208
VMEDRay Dalio 2011-09-30 Add0.03%$20.93 - $30.57
($25.55)
$ 50.3697%Add 141.43%161,008
VMEDGeorge Soros 2011-09-30 Sold Out -0.0058%$20.93 - $30.57
($25.68)
$ 50.3696%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VMED is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VMED Jean-Marie Eveillard 2013-03-31508,5550.190.08New Buy
VMED Daniel Loeb 2013-03-3111,000,0004.0810.1New Buy
VMED Steve Mandel 2013-03-315,659,8082.11.4New Buy
VMED Mario Gabelli 2013-03-31109,7300.040.03New Buy
VMED George Soros 2013-03-311,674,8500.620.96+958.36%
VMED David Einhorn 2013-03-314,920,0001.833.7
VMED John Griffin 2013-03-311,650,0000.611-64.13%
VMED Andreas Halvorsen 2013-03-31000Sold Out
VMED Ray Dalio 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VMED: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chiddix James A.Director 2013-05-10Sell19,000$50.92-1.1view
COLE ANDREWDirector 2013-05-10Sell100,800$50.9-1.06view
ZOFFINGER GEORGE RDirector 2013-05-08Sell14,725$51.64-2.48view
RIGSBY JOHN NDirector 2013-05-03Sell10,000$49.771.19view
BARRON ANDREWCHIEF OPERATING OFFICER 2013-05-03Sell96,449$49.581.57view
Berkett NeilCHIEF EXECUTIVE OFFICER 2013-05-03Sell365,620$49.841.04view
TOBEN DOREEN ADirector 2013-05-02Sell10,656$49.591.55view
BUTTERY PAULCHIEF C T & N OFFICER 2013-05-01Sell77,609$48.873.05view
BUTTERY PAULCHIEF C T & N OFFICER 2013-04-02Buy0$49.661.41view
OHARE EAMONNCHIEF FINANCIAL OFFICER 2013-03-15Sell10,000$46.677.91view

Press Releases about VMED:

Quarterly/Annual Reports about VMED:

    News about VMED:

    Articles On GuruFocus.com
    New Buys of Jeremy Grantham May 14 2013 
    Third Point Update and Top Three May 10 2013 
    Mario Gabelli Surges to Record $40B AUM; Dell, Acme Packet and Boulder Brands Top List of New Buys May 10 2013 
    Large Insider Sells Reported in the Entertainment Industry May 10 2013 
    My 3 Favorite Services Dividend Stocks with Cheap Forward Price Ratios May 08 2013 
    Daniel Loeb Comments on Liberty Global Apr 11 2013 
    Daniel Loeb's Q1 Letter - Comments on Liberty Global, Japan, International Paper, Mortgages Apr 10 2013 
    Daniel Loeb Reports New Top Position – Virgin Media Mar 11 2013 
    Best Dividend-Paying Shares on March 8, 2013 Mar 07 2013 
    Early Movers for Feb. 6, 2013 Feb 06 2013 

    More From Our Partners
    Virgin Media Remains Neutral - Analyst Blog May 17 2013 - ZACKS

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
    Free 7-day Trial